Latest news
CMPX: Strong pipeline progress and solid cash position support continued clinical development - TradingViewTradingView · Thu, 06 Aug 2026 11:32:04 GMTVRDN: FDA approval and strong clinical data drive growth prospects in TED and autoimmune markets - TradingViewTradingView · Thu, 06 Aug 2026 11:18:45 GMTCGEM: Pipeline advances and strong cash position support growth and late-stage clinical milestones - TradingViewTradingView · Thu, 06 Aug 2026 11:16:47 GMTIMVT: IMVT-1402 clinical development advances on track, with strong cash reserves and rising R&D spend - TradingViewTradingView · Thu, 06 Aug 2026 11:02:04 GMTGRAL: Q2 2026 delivered strong revenue growth and clinical milestones, with FDA approval anticipated in 2027 - TradingViewTradingView · Wed, 05 Aug 2026 22:30:31 GMTPACB: Q2 2026 saw $39.0M revenue, strong clinical growth, and rapid SPRQ-Nx adoption amid margin pressure - TradingViewTradingView · Wed, 05 Aug 2026 20:12:25 GMTWW: Q2 2026 delivered strong clinical growth, robust cash flow, and reaffirmed full-year guidance - TradingViewTradingView · Wed, 05 Aug 2026 20:12:14 GMTAORT: Double-digit growth driven by innovative aortic products, strong clinical data, and expanding markets - TradingViewTradingView · Sat, 01 Aug 2026 20:27:33 GMT